- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
CELL DEATH IN RESPONSE TO GENOTOXIC STRESS AND DNA DAMAGE |
75 |
|||
|
|
|
|
|
|
Table 8-1. DNA lesions and repair pathways |
|
|
|
|
|
|
|
|
|
|
|
DNA repair |
|
|
Source of damage |
Type of damage |
pathway |
|
|
|
|
|
|
|
Ultraviolet radiation |
Cyclobutane pyrimidine dimers (TT, TC, CT, or CC) |
NER |
|
|
Ultraviolet radiation |
Bulky or helix-distorting DNA lesions |
NER |
|
|
Ultraviolet radiation |
(6-4) photoproducts |
NER |
|
|
Ionizing radiation |
Double-strand breaks |
HR/NHEJ |
|
|
Ionizing radiation |
Single-strand breaks |
BER |
|
|
Ionizing radiation |
Oxidative base damage |
BER |
|
|
Mitomycin |
Interstrand crosslinks |
RR |
|
|
Cisplatin |
Intrastrand crosslink |
NER |
|
|
Alkylating agents |
O6-alkylguanine |
DRD |
|
|
Alkylating agents, spontaneous hydrolysis |
Non–helix-distorting base modifications, abasic sites |
BER |
|
|
Aldehydes |
DNA adducts |
NER |
|
|
ROS |
Oxidative base damage |
BER |
|
|
ROS |
Cyclopurines (A or G) making bulky lesions |
NER |
|
|
Replication errors |
Mismatches, small insertions or deletions |
MMR |
|
|
Collapsed replication forks |
One-ended double-strand breaks |
HR |
|
|
|
|
||
|
Note: BER, base excision repair; DRD, direct reversal of damage; HR, homologous recombination; MMR, mismatch repair; NER, nucleotide excision repair; NHEJ, |
|
||
|
nonhomologous end joining; RR, recombinational repair; ROS, reactive oxygen species. |
|
|
|
|
|
|
|
|
finally reestablishing the original DNA content using pathway-specific polymerases and ligases. Base excision repair acts during all cell cycle stages and is often responsible for correcting damages that arise spontaneously due to the inherent instability of DNA or due to exposure to intercalating (i.e., anticancer) agents and environmental mutagens that generate free radicals. Nucleotide excision repair largely acts independently of the cell cycle to remove bulky DNA adducts, such as UV-induced cyclobutane pyrimidine dimers, DNA cross-links, and certain oxidative base modifications. Mismatch repair acts to remove not only mismatches, but also small insertions or deletions that arise as replication errors or that arise during recombination.
Direct reversal of damage is a highly specialized repair mechanism. In humans, only the MGMT (O6-methyl- guanine-DNA methyltransferase) protein is known to function by this repair mechanism and irreversibly accepts the methyl group directly from the modified base.
Recombinational repair is required to repair DSB and is thus especially important in response to IR. DSBs are among the most harmful of lesions because they affect both strands of the double helix, meaning that one strand of DNA cannot act as a template for the repair of the other. There are two forms of DSBs: (1) twoended breaks, generated primarily by direct attack on DNA by a physical or chemical mutagen such as IR, and
(2) one-ended breaks, created when the replication fork collides into an unrepaired DNA single-strand break. One-ended breaks appear to be resolved strictly by classical homologous recombination. Two-ended breaks are repaired by three major repair mechanisms: (1) homologous recombination, (2) single-strand annealing, and (3) nonhomologous end-joining. Homologous recombination usually takes place after DNA replication (i.e., during S or G2 phase of the cell cycle) and is largely errorfree. An undamaged, homologous molecule such as a sister chromatid provides the repair template. On the other hand, single-strand annealing is an error-prone repair system. Homologous sequences (usually repetitive elements) on either side of the DSB are aligned followed by the deletion of the intermediate noncomplementary sequence. Nonhomologous end joining (NHEJ) is the major DSB repair pathway that takes place during the G1 phase of the cell cycle. This pathway is prone to errors because it fuses together two ends of a DSB.
2. DNA DAMAGE RESPONSE
An important question in cell biology is how the cell detects DNA damage. The cellular response to genotoxic stress can be envisioned as a highly conserved signal transduction cascade: the DNA damage response (DDR) (Figure 8-1). Sensor proteins are the first to detect DNA damage and replication stress. They then
76 |
PABLO LOPEZ-BERGAMI AND ZE’EV RONAI |
RAD17
RPA
HUS1
RAD1
RAD9
ATR ATM
Chk1
|
|
of the replication fork, which gener- |
||
|
|
ates single-strand DNA that is sensed |
||
|
|
and bound by the single-strand binding |
||
|
|
protein complex replication protein A. |
||
|
|
The multiprotein complexes rapidly |
||
|
|
expand to form nuclear foci (DNA |
||
RAD50 MRE11 |
|
damage heterochromatin foci). Highly |
||
|
dynamic and massive (giga-Dalton |
|||
NBS1 |
Response |
sized), the foci contain hundreds of |
||
|
individual DNA repair and checkpoint |
|||
|
proteins, |
modified chromatin, and |
||
|
damaged DNA. Foci, a punctuate or |
|||
|
speckle seen on immunostaining with |
|||
DNA-PK |
Damage |
|||
antibodies, is a hallmark of the DNA |
||||
|
||||
|
damage response, and its main func- |
|||
|
tion is to cluster DNA damage response |
|||
|
A |
|||
|
|
|
||
Chk2 |
DN |
proteins |
at the damaged sites. Foci |
|
are often seen within minutes after |
||||
|
||||
|
|
|||
|
|
DNA damage and remain visible up to |
||
BRCA1 |
|
24 hours after the damage, long after it |
||
|
is repaired. |
|||
Mdm2 |
|
2.2. Transducers
Various kinases of the phosphoino- sitide-3-kinase-related protein kinase (PIKK) family, including ataxia-telang- iectasia mutated (ATM) kinase (the gene altered in this recessive human genomic instability syndrome), ATMand Rad3-related (ATR) kinase, and
DNA-dependent protein kinase (DNA-PK), constitute the primary transducers of the DNA damage response. Within minutes of the DSB formation, ATM is recruited to the foci and activated. Active phosphorylated ATM remains stable for many hours. Unlike ATM, the ATR gene and its canonical substrate, Chk1, are essential in mice, underscoring their important role in normal cell growth. The ATR pathway is normally activated by stalled replication forks during DNA replication and thus plays an essential role in maintaining genome integrity during S phase. UV light, single-strand DNA, and presumably all chemical agents that give rise to stalled DNA replication forks also strongly activate the ATR pathway.
ATR is recruited by the single-strand DNA-RPA complex that also recruits and activates Rad17 and the proliferating cell nuclear antigen (PCNA)–related 911 (Rad9- Rad1-Hus1) complex. ATR phosphorylation of Rad17 and 911 is important for downstream signaling. It is not yet clear how ATR is activated when recruited to singlestrand DNA lesions, although both the 911 complex and TopBP1, another protein in the complex, have been
CELL DEATH IN RESPONSE TO GENOTOXIC STRESS AND DNA DAMAGE |
77 |
tumor suppressors, and chromatin remodeling, were also identified among ATM/ATR substrates.
3. INTEGRATION OF ATM AND
ATR PATHWAYS
Figure 8-2. In response to DNA damage, the cell activates checkpoint arrest to facilitate
repair of damage. On successful repair, the cell cycle resumes. If DNA damage is too severe Because ATM and ATR respond to very
or cannot be repaired, the cell activates senescence or apoptosis. |
different stimuli, they have been con- |
|
|
sidered analogous components of inde- |
|
shown to stimulate ATR kinase activity. ATM and DNA- |
pendent and parallel pathways but with distinct inputs |
|
PK activity is preferentially triggered by DSBs induced by |
and outputs. However, multiple genomic insults even- |
|
IR. ATM exists as inactive dimers that, when recruited |
tually activate both kinases, which ultimately trigger |
|
by the Mre11, Rad50, and Nbs1 (MRE) complex to the |
Chk1 and Chk2 activation. ATR responds robustly to |
|
foci, become activated on multiple residues by dissocia- |
DSBs, and the response is ATM-dependent. The recruit- |
|
tion and autophosphorylation. The MRN complex is also |
ment of ATR to the location of DSBs by ATM appears to |
|
a substrate of ATM whose phosphorylation is important |
be an indirect effect because ATM triggers the formation |
|
for downstream signaling. |
of a DNA-protein structure that provides a strong stim- |
|
|
ulus for ATR signaling. Similarly, UV and hydroxyurea, |
|
2.3. Effectors |
both potent activators of ATR signaling, also activate |
|
ATM and, importantly, this activation is ATR-dependent. |
||
|
||
ATM and ATR regulate cell cycle progression and arrest, |
Collectively, these studies demonstrate that ATM and |
|
DNA repair systems, cellular senescence, and apopto- |
ATR function as an integrated molecular circuit to pro- |
|
sis by activating a host of effector proteins (Figure 8-2). |
cess diverse signals. Consequently, they effectively link |
|
After the DNA damage response is activated, phospho- |
the DNA replication apparatus with DDR pathways. Sup- |
|
rylation (mediated by ATM and ATM) and other post- |
portive of this cross-talk between ATM and ATR is that |
|
transcriptional modifications (notably, ubiquitination |
both phosphorylate the same consensus sequence on |
|
and methylation) induce chromatin remodeling and fur- |
their substrates. |
|
ther recruitment of proteins such as p53, Mdm2, BRCA1, |
|
|
FANCD2, and NBS1 to the foci. The identity of the pro- |
4. CHROMATIN MODIFICATIONS |
|
teins that regulate DNA repair and the damage signal |
||
|
||
depends on the nature of the damage and during what |
Efficient repair of DNA damage is challenged by the |
|
phase of the cell cycle that the damage has taken place. |
physical state of genomic DNA, which is highly com- |
|
Several adaptor proteins, including 53BP1, BRCA1, |
pacted and condensed within the chromatin. The |
|
MDC1, and claspin, organize the synchronized recruit- |
most basic component of chromatin, the nucleosome, |
|
ment of DNA damage response proteins, as well as the |
consists of 147 bp of DNA wrapped around a his- |
|
function of downstream kinases such as checkpoint- |
tone octamer (two copies each of histones H2A, H2B, |
|
1 (Chk1) and checkpoint-2 (Chk2). ATR induces Chk1 |
H3, and H4). To manipulate the chromatin-packaged |
|
phosphorylation at Ser317 and Ser345, which is thought |
state of DNA, specialized mechanisms have evolved, |
|
to facilitate Chk1 function. ATM induces Chk2 phos- |
including covalent histone modifications (phosphory- |
|
phorylation at Thr68, which triggers Chk2 activation |
lation, methylation, acetylation, ubiquitination, sumoy- |
|
through homodimerization and autophosphorylation at |
lation, and adenosine diphosphate ribosylation), ATP- |
|
Thr383 and Thr387. To date, more than 700 proteins have |
dependent chromatin remodeling, and histone variant |
|
been identified as candidate substrates phosphorylated |
incorporation. |
|
by ATM and ATR in response to IR or UV. The studies |
DNA damage triggers alterations in chromatin struc- |
|
revealed proteins involved in DNA replication and var- |
ture, including dynamic and specific post-translational |
|
ious DNA repair mechanisms, highlighting the critical |
covalent modifications of histone proteins that are |
|
role of the DDR in controlling genomic stability. Inter- |
thought to play critical roles in surveillance, detection, |
|
estingly, proteins belonging to pathways not directly |
and repair. The first damage-specific histone modifica- |
|
implicated in the DDR, such as insulin signaling, RNA |
tion identified was phosphorylation of H2A S129 (H2AX |
|
splicing, nonsense-mediated RNA decay, the spindle |
S139 in mammalian cells) by ATM/ATR and DNA-PK. |
|
checkpoint, mitotic spindle and kinetochore proteins, |
H2AX phosphorylation occurs immediately after a DSB |
78 |
PABLO LOPEZ-BERGAMI AND ZE’EV RONAI |
and has become a standard marker for such damage. Although unnecessary to promote the initial steps of the repair process, this modification is needed to concentrate repair machineries along the DNA lesions and to recruit chromatin modifiers such as complexes INO80, Swr1, and NuA4, which relaxes the chromatin structure surrounding the DNA lesion.
PP2A dephosphorylation of H2AX has been recently shown to be significant in turning off the damage response. Other H2A modifications have been identified as signals for general damage or stress, whereas others play roles in distinct repair pathways. Specifically, H2A phosphorylation of S122 and S129 is required to repair DSBs either by homologous recombination or NHEJ pathways. Other residues have even more specific roles: T126 is important for homologous recombination but dispensable for NHEJ, whereas S2 and K127 are critical for NHEJ but have no role in homologous recombination. These data indicate that both the type of damage and selected repair pathway are marked by specific H2A modifications, creating a unique histone code for each type of damage and repair.
Another covalent histone modification implicated in the DNA damage response is the methylation of histone H3 at lysine 79 (H3K79me) by the histone methyltransferase Dot1. Unlike γH2AX, DNA damage does not induce H3K79me but is constitutively present on chromatin. Otherwise, DNA damage would increase the accessibility of methylated H3K79me, allowing 53BP1 to instead act during the early sensing step. Similarly, H4K20 plays an analogous role in recruiting Crb2.
Histone acetylation not only functions in protein recruitment, but also acts to relax the chromatin structure and therefore facilitates access of DSB repair proteins such as 53BP1, BRCA1, and Rad51 to the lesion. The acetylation status of histones is regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), and some of these HATs and HDACs are recruited to the lesion.
In addition to covalent histone modifications mentioned previously, chromatin is directly manipulated by adenosine triphosphate (ATP)–dependent chromatin remodeling complexes. These complexes use energy from ATP hydrolysis to facilitate chromatin remodeling through nucleosome sliding, nucleosome disruption, and exchange of histone components. Although the roles of many ATP-dependent remodeling complexes were first identified in transcriptional regulation, it has recently been shown that some of these complexes (e.g., INO80, RSC, SWI/SNF, and SWR-C) are also recruited for DNA repair.
5. CELL CYCLE CHECKPOINT REGULATION
One of the primary responses to DNA damage besides stimulation of DNA repair is the activation of cell cycle checkpoints. Cell cycle checkpoints are regulatory pathways that control the order and timing of cell cycle transitions and ensure that critical processes at each phase of the cell cycle, such as DNA replication and chromosome segregation, are completed with high fidelity before progressing to the next phase. A timely cell cycle progression results in the correct transmission of genetic information from parent to daughter cells. When stimulated with suitable growth factors, quiescent cells leave the cell cycle’s resting phase, called gap 0 (G0), and enter gap 1 (G1) phase, then segue to DNA replication or synthesis
(S) phase, which is followed by a second gap (G2) phase, and finally on to cell division or mitosis (M). DNA damage effect on cell cycle is mainly seen in three checkpoints: (1) G1/S (G1), (2) intra-S phase, and (3) G2/M. When DNA damage is sensed, cells arrest the cell cycle at these specific phases by activating the appropriate DNA damage checkpoint(s). For instance, on perturbation of DNA replication by normal, stalled replication forks or by drugs that interfere with DNA synthesis, cells activate the checkpoint that arrests the cell cycle at G2/M transition until DNA replication is complete. Checkpoint pathways also induce transcription of genes that contribute to the repair and its quality control.
Checkpoint activation is mediated by transcriptional and post-transcriptional modifications of proteins that regulate the cell cycle. Such regulation is carried out by oscillations in cycling-dependent kinases (Cdks), which are positively regulated by cyclins (cdk-cyclin complexes) and by dephosphorylation (mediated by the dual specificity Cdc25 phosphatase family, including Cdc25A, Cdc25B, and Cdc25C); Cdks are negatively regulated by Cdk inhibitors and Wee1 and Mik1 kinase-dependent phosphorylation within the ATP-binding domain. The cdk-cyclin complexes influencing G1 progression and the G1/S checkpoint are primarily Cdk4-cyclin D, Cdk6cyclin D, and Cdk2-cyclin E, whereas Cdk2-cyclin E complexes normally promote the G1/S transition.
Progression into S phase, and transition from G2 into M, is regulated by Cdk2/cyclin A and Cdk1/cyclin B, respectively. During the DNA damage response, activation of ATM/ATR and Chk1 and Chk2 kinases leads to phosphorylation of all three Cdc25 phosphatases. Chk1 or Chk2 phosphorylation of Cdc25 leads to inhibitory sequestration of Cdc25C by 14–3-3 proteins and ubiquitin-mediated proteolysis of Cdc25A. Cdc25A acts earlier in the cell cycle than Cdc25B and Cdc25C, is thought to be important for maximal Cdk